Catalyst Pharmaceuticals Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Catalyst Pharmaceuticals Inc 's ROA in the first quarter of 2026?
Catalyst Pharmaceuticals Inc achieved a return on average assets (ROA) of 20.71 % in its first quarter of 2026, this is above CPRX's average return on assets of -9.45%.
Catalyst Pharmaceuticals Inc assets over the 12 months ending in its first quarter of 2026 are valued at $1,069 million

ROA fell compared to the fourth quarter of 2025, despite the net income growth of 20.94% from the fourth quarter of 2025.

However, within the Healthcare sector 48 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 223, from total ROA ranking in the fourth quarter of 2025 at 237.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	26.27 %	28.14 %	36.22 %	37.59 %	40.55 %
Y / Y Net Income Change	12.33 %	-5.79 %	20.28 %	27.73 %	143.77 %
Net Income (TTM) in million	221	214	218	209	197
Return On Assets (TTM)	20.71 %	21.24 %	22.94 %	23.75 %	24.3 %
CPRX's Total Ranking	# 223	# 237	# 199	# 192	# 177
Total Assets (TTM) in million	1,148	1,104	1,052	972	909
Seq. Total Assets Change	3.95 %	4.98 %	8.2 %	6.94 %	5.5 %
Seq. Net Income Change	20.94 %	-0.16 %	1.3 %	-8.16 %	1.43 %

CPRX's 5 Years Annual ROA >> Back to CPRX Management Effectiveness >> Compare CPRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 27
Sector	# 49
Overall	# 219

Return On Assets Statistics
High	Average	Low
53.29 %	-9.45 %	-83.61 %
(Sep 30 2020)		(Jun 30 2012)

Financial Statements
Catalyst Pharmaceuticals Inc 's Assets	$ 1,148 million	CPRX's Balance sheet
Catalyst Pharmaceuticals Inc 's Income	$ 64 million	Quarterly CPRX's Income Statement
CPRX's Income by Division		See CPRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	29.66 %	81.11 %	25.15 %	57.97 %	23.62 %
Total Assets in million	1,104	851	470	376	238
Y / Y Net Income Change	30.78 %	129.5 %	-14.05 %	110.42 %	-47.35 %
Net Income in million	214	164	71	83	39
Annual Return On Assets	19.41 %	19.25 %	15.19 %	22.12 %	16.6 %

CPRX's 5 Years Annual ROA >> Back to CPRX Management Effectiveness >> Compare CPRX ROA to its Competitors

Comment on CPRX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 19.41 % compared to prior year, due to annual net income growth of 30.78 % to $214.33 million, while value of Catalyst Pharmaceuticals Inc 's overall assets grew just by 29.66 % to $1,103.98 million, compared to $1,103.98 a year before.

More Return On Assets Ratios
CPRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CPRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CPRX's Competitors
Subscribers only: Roa for Catalyst Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for CPRX's Customers

You may also want to know
CPRX's Roi	CPRX's Inventory Turnover Ratio	CPRX's Growth Rates	CPRX's Dividend Comparisons
	CPRX's Profitability Ratios	CPRX's Asset Turnover Ratio	CPRX's Dividend Growth
CPRX's Roe	CPRX's Valuation Ratios	CPRX's Financial Strength Ratios	CPRX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector	ROA
Q32 Bio Inc	53.33 %
Coherus Oncology inc	50.33 %
Oramed Pharmaceuticals Inc	49.88 %
Aurinia Pharmaceuticals Inc	47.61 %
Zevra Therapeutics Inc	45.60 %
Earth Science Tech Inc	44.55 %
Tg Therapeutics Inc	42.77 %
Lensar Inc	42.26 %
Elite Pharmaceuticals Inc	38.74 %
Dariohealth Corp	37.08 %
Omeros Corporation	34.53 %
Idexx Laboratories Inc	32.56 %
Innoviva Inc	32.36 %
Agenus Inc	30.03 %
Abeona Therapeutics Inc	29.55 %
Escalon Medical Corp	29.20 %
Protagenic Therapeutics Inc new	27.96 %
Adma Biologics Inc	27.37 %
Rafael Holdings Inc	26.85 %
Acadia Pharmaceuticals Inc	26.24 %
Ironwood Pharmaceuticals inc	26.02 %
Theravance Biopharma inc	25.46 %
Spero Therapeutics Inc	24.95 %
Medpace Holdings Inc	24.79 %
Mettler toledo International Inc	24.47 %
Qhslab Inc	23.09 %
Eli Lilly And Company	22.73 %
Incyte Corporation	21.65 %
Iradimed Corporation	21.25 %
Catalyst Pharmaceuticals Inc	20.71 %

Date modified: 2026-06-22T14:32:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.